pace up pharmaceuticals LLC

200 bangor street
lindenhurst, new york 11757

NYS Entity Status
ACTIVE

NYS Filing Date
SEPTEMBER 18, 2014

NYS DOS ID#
4638305

County
SUFFOLK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - PACE UP PHARMACEUTICALS LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • The Strange Case of Martin Shkreli Is Wrapping Up
    By STEPHANIE CLIFFORD - Wednesday Jul 26, 2017

    An unusual trial has featured victims who actually made money and defense lawyers who paint their client as an erratic misfit and want more victims to testify.

    Source: NYT > Home Page
  • The Pop-Up Employer: Build a Team, Do the Job, Say Goodbye
    By NOAM SCHEIBER - Wednesday Jul 12, 2017

    “Flash organizations,” modeled on filmmaking, find their way into fields like software and pharmaceuticals, assembling freelancers and then disbanding.

    Source: NYT > Home Page
  • Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
    Monday Oct 16, 2017

    Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.

    Source: The Wall Street Journal: U.S. Business
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Shareholders Demand More Drastic Shifts at Nestlé
    By STEPHANIE STROM - Tuesday Jun 27, 2017

    The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.

    Source: NYT > Home Page